Clinical Trials

Title   Phase 3 open-label, controlled, randomized, multicenter study evaluating the efficacy and safety of Stratagraft® skin tissue in promoting autologous skin tissue regeneration of complex skin defects due to thermal burns that contain intact dermal elements
Description   The proposed registration study is designed as a phase III open-label, controlled, randomized, multicenter study evaluating the efficacy and safety of StrataGraft skin tissue in promoting autologous skin tissue regeneration of complex skin defects due to thermal burns.
IRB Number   17-344
Treatment   Thermal Burns
Status   Active
Start Date   09/12/2017
Principal Name   Steven Kahn M.D.
Contact Name   Kelley Prutzman

Email Newsletters

Connect With Us